NAD Augmentation to Prevent or Reverse Alzheimer's Disease in People With Down Syndrome
Clinical trial NCT07278492 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07278492
- Sponsor
- Brigham and Women's Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-07
- Primary completion
- 2028-02-29
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.